KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$2.64
+0.08 (+3.13%)
Open$2.60
Previous Close$2.56
Day High$2.64
Day Low$2.58
52W High$3.01
52W Low$1.76
Volume—
Avg Volume23.8K
Market Cap11.44M
P/E Ratio—
EPS$-2.62
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,011.4% upside
Current
$2.64
$2.64
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.53M | 8.57M | 1.95M |
| Net Income | 3.48M | 1.73M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 4.31M | 2.26M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |